Bata India - Steady Revenue Recovery To Aid Premiumisation Play: ICICI Direct
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
ICICI Direct Report
Bata India Ltd. appears to be well placed to benefit from normalisation of demand scenario.
Channel checks suggest a healthy recovery in August-September with discretionary retailers witnessing recovery rate of more than 80% of pre-Covid-19 levels (versus 50% in past year).
Bata India’s core product portfolio includes formal and fashion footwear category.
While open footwear and slippers category witnessed speedy recovery (as witnessed in financials of Relaxo), fewer social gatherings and office/school closures had a material impact on performance of the company in FY21.
Average selling prices declined ~14% to Rs 535/pair with gross margin declining 660 basis points YoY in FY21.
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.